NPI: 1124032982 · BROOKLYN, NY 11235 · Internal Medicine Physician · NPI assigned 07/28/2006
Authorized official KARLIN, MARJI controls 19+ related entities in our dataset. Read more
| Authorized Official | KARLIN, MARJI (CHIEF REVENUE OFFICER) |
| NPI Enumeration Date | 07/28/2006 |
Other providers sharing the same authorized official: KARLIN, MARJI
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 40,510 | $239K |
| 2019 | 157,580 | $6.13M |
| 2020 | 371,677 | $17.50M |
| 2021 | 696,526 | $29.53M |
| 2022 | 556,618 | $25.14M |
| 2023 | 323,253 | $14.37M |
| 2024 | 297,891 | $14.44M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 70,125 | 63,626 | $13.13M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 143,462 | 121,621 | $10.27M |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 97,863 | 80,512 | $8.36M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 36,195 | 31,290 | $6.99M |
| 36415 | Collection of venous blood by venipuncture | 299,261 | 99,236 | $4.82M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 19,825 | 18,151 | $4.05M |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 33,992 | 29,844 | $3.81M |
| 96361 | Intravenous infusion, hydration; each additional hour | 43,788 | 15,138 | $3.18M |
| G0378 | Hospital observation service, per hour | 2,642 | 2,280 | $2.87M |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 130,364 | 108,192 | $2.35M |
| 90832 | Psychotherapy, 30 minutes with patient | 13,711 | 9,151 | $1.88M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 8,984 | 8,517 | $1.67M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 21,548 | 18,342 | $1.63M |
| 70450 | Computed tomography, head or brain; without contrast material | 6,217 | 5,969 | $1.58M |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 65,444 | 55,869 | $1.50M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 22,239 | 18,088 | $1.44M |
| J2426 | Injection, paliperidone palmitate extended release (invega sustenna), 1 mg | 1,098 | 1,026 | $1.30M |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 43,678 | 25,598 | $1.11M |
| 90834 | Psychotherapy, 45 minutes with patient | 5,731 | 3,830 | $1.10M |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 8,182 | 7,953 | $1.03M |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 7,889 | 5,803 | $925K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 8,614 | 7,437 | $844K |
| J0401 | Injection, aripiprazole (abilify maintena), 1 mg | 852 | 720 | $837K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 10,021 | 2,936 | $813K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 5,445 | 5,358 | $793K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 6,970 | 6,726 | $757K |
| 86480 | 13,352 | 13,165 | $747K | |
| H0040 | Assertive community treatment program, per diem | 542 | 498 | $701K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3,491 | 3,447 | $694K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 14,888 | 13,259 | $677K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 5,780 | 2,665 | $660K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 4,145 | 4,077 | $656K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 16,532 | 12,455 | $636K |
| 99442 | 7,571 | 7,151 | $562K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 12,996 | 12,745 | $530K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 1,537 | 1,520 | $503K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 6,856 | 6,621 | $476K |
| 80048 | Basic metabolic panel (calcium, ionized) | 35,602 | 33,045 | $443K |
| 99215 | Prolong outpt/office vis | 2,752 | 2,596 | $436K |
| D9999 | Unspecified adjunctive procedure, by report | 3,138 | 2,979 | $427K |
| 80053 | Comprehensive metabolic panel | 33,685 | 31,795 | $418K |
| H0001 | Alcohol and/or drug assessment | 2,509 | 2,087 | $414K |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | 944 | 937 | $410K |
| 99443 | 3,273 | 3,142 | $356K | |
| H0004 | Behavioral health counseling and therapy, per 15 minutes | 5,887 | 2,910 | $351K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1,721 | 1,704 | $347K |
| D0999 | Unspecified diagnostic procedure, by report | 2,136 | 2,102 | $341K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 11,367 | 11,121 | $341K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 2,690 | 2,587 | $340K |
| 76818 | 2,768 | 1,479 | $331K | |
| 76770 | 1,331 | 1,317 | $321K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 21,200 | 19,564 | $319K |
| 99205 | Prolong outpt/office vis | 1,550 | 1,518 | $305K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 3,089 | 2,855 | $304K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 1,577 | 1,512 | $260K |
| 86850 | 10,646 | 9,818 | $259K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 15,012 | 13,632 | $254K |
| 12001 | 731 | 694 | $245K | |
| 81408 | 212 | 212 | $244K | |
| 85027 | 79,957 | 73,928 | $242K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 8,717 | 8,615 | $242K |
| 12011 | 746 | 712 | $240K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 9,805 | 9,581 | $237K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 22,937 | 22,658 | $221K |
| 99201 | 2,022 | 1,952 | $220K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 4,715 | 3,295 | $212K |
| H0005 | Alcohol and/or drug services; group counseling by a clinician | 2,652 | 663 | $209K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 2,010 | 1,913 | $208K |
| 76641 | 1,655 | 1,431 | $207K | |
| 81420 | Fetal chromosomal aneuploidy genomic sequence analysis panel | 287 | 286 | $202K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1,537 | 1,528 | $202K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 1,914 | 1,793 | $196K |
| H0002 | Behavioral health screening to determine eligibility for admission to treatment program | 1,044 | 965 | $194K |
| 80061 | Lipid panel | 18,379 | 18,109 | $193K |
| 0002A | 6,149 | 6,135 | $191K | |
| 84443 | Thyroid stimulating hormone (TSH) | 19,227 | 18,629 | $190K |
| 93970 | 542 | 535 | $182K | |
| 86901 | 10,812 | 9,859 | $179K | |
| 0001A | 6,319 | 6,310 | $179K | |
| J2315 | Injection, naltrexone, depot form, 1 mg | 151 | 141 | $169K |
| 90791 | Psychiatric diagnostic evaluation | 764 | 692 | $163K |
| 96161 | 9,966 | 7,107 | $161K | |
| 70486 | 1,291 | 1,258 | $160K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 230 | 230 | $157K |
| 80076 | 21,968 | 20,897 | $157K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 21,731 | 21,068 | $152K |
| 86703 | 11,777 | 11,609 | $152K | |
| 99441 | 3,251 | 3,171 | $146K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 1,683 | 1,610 | $143K |
| 87486 | 5,513 | 5,425 | $141K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 2,438 | 2,371 | $139K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 6,057 | 5,990 | $137K |
| 90461 | 10,011 | 9,955 | $132K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 5,214 | 5,182 | $130K |
| 97802 | 2,837 | 2,790 | $128K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 684 | 677 | $128K |
| 71046 | Radiologic examination, chest; 2 views | 10,966 | 10,710 | $128K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 974 | 959 | $124K |
| 83655 | 11,012 | 10,896 | $123K | |
| 90677 | 1,274 | 1,271 | $122K | |
| 86900 | 10,780 | 9,835 | $122K | |
| 59025 | Fetal non-stress test | 816 | 736 | $121K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 709 | 698 | $121K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 19,982 | 19,429 | $121K |
| 84703 | 27,269 | 24,628 | $113K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 170 | 168 | $113K |
| 90651 | 1,272 | 1,263 | $108K | |
| 90715 | 4,498 | 4,458 | $108K | |
| 85610 | 20,809 | 14,612 | $106K | |
| 99381 | 2,472 | 1,949 | $101K | |
| 87581 | 5,514 | 5,426 | $100K | |
| D2930 | Prefabricated stainless steel crown - primary tooth | 589 | 589 | $97K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 2,432 | 909 | $91K |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | 2,298 | 2,103 | $89K |
| 82805 | 8,680 | 8,187 | $88K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 11,641 | 10,892 | $85K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1,860 | 1,138 | $85K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 3,814 | 3,436 | $84K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 6,564 | 4,495 | $83K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 498 | 498 | $81K |
| 0004A | 1,991 | 1,984 | $77K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1,002 | 969 | $76K |
| D2335 | 279 | 279 | $74K | |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 73 | 52 | $73K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 2,228 | 2,163 | $71K |
| 90686 | 7,834 | 7,761 | $71K | |
| 76820 | 1,409 | 822 | $70K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 6,078 | 5,798 | $70K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 2,311 | 2,012 | $69K |
| H0050 | Alcohol and/or drug services, brief intervention, per 15 minutes | 1,498 | 1,360 | $69K |
| 86769 | 1,994 | 1,937 | $65K | |
| 90750 | 855 | 846 | $65K | |
| 86780 | 7,425 | 7,213 | $65K | |
| 76536 | 528 | 525 | $64K | |
| 87536 | 679 | 661 | $63K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1,926 | 1,862 | $63K |
| 84439 | 10,198 | 9,916 | $63K | |
| 83880 | 3,524 | 3,435 | $62K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 2,097 | 849 | $59K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 209 | 208 | $58K |
| T1013 | Sign language or oral interpretive services, per 15 minutes | 6,275 | 5,773 | $57K |
| 86803 | 5,681 | 5,607 | $56K | |
| 82607 | 4,839 | 4,760 | $55K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 665 | 659 | $53K |
| 90746 | 1,004 | 993 | $53K | |
| 97803 | 1,069 | 1,060 | $53K | |
| 87800 | 1,609 | 1,576 | $52K | |
| 12002 | 148 | 138 | $52K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 923 | 919 | $50K |
| D3220 | Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction | 628 | 628 | $50K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 174 | 172 | $47K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 1,620 | 1,612 | $45K |
| 76801 | 346 | 331 | $45K | |
| 73630 | 2,620 | 2,434 | $45K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 13,499 | 12,695 | $43K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 84 | 83 | $43K |
| 88142 | 1,795 | 1,766 | $41K | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 489 | 245 | $41K |
| 97014 | 2,271 | 754 | $41K | |
| 81001 | 29,018 | 27,119 | $39K | |
| 90670 | 2,678 | 2,666 | $39K | |
| 96127 | 11,741 | 9,942 | $38K | |
| 80320 | 13,370 | 10,912 | $38K | |
| 84702 | 6,864 | 5,926 | $38K | |
| 86360 | 801 | 776 | $37K | |
| 87340 | 5,057 | 4,932 | $37K | |
| 81329 | 305 | 303 | $37K | |
| D7250 | 250 | 249 | $36K | |
| 29125 | 172 | 161 | $35K | |
| 73564 | 1,720 | 1,585 | $35K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | 164 | 157 | $35K |
| 72100 | 1,560 | 1,540 | $34K | |
| 90697 | 1,399 | 1,398 | $33K | |
| 73610 | 2,209 | 1,994 | $33K | |
| H0049 | Alcohol and/or drug screening | 695 | 642 | $33K |
| 96367 | 996 | 940 | $33K | |
| 0072A | 779 | 777 | $32K | |
| 0071A | 817 | 813 | $31K | |
| 86359 | 795 | 770 | $30K | |
| 90680 | 2,534 | 2,530 | $30K | |
| 71045 | Radiologic examination, chest; single view | 5,116 | 4,959 | $30K |
| 83970 | 873 | 835 | $30K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 366 | 359 | $30K |
| 82728 | 2,979 | 2,904 | $29K | |
| 81161 | 182 | 182 | $28K | |
| 97162 | 249 | 246 | $28K | |
| 76000 | 229 | 216 | $27K | |
| 73110 | 1,892 | 1,527 | $27K | |
| 86762 | 2,419 | 2,337 | $26K | |
| 97010 | 2,886 | 1,013 | $25K | |
| G0397 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and intervention, greater than 30 minutes | 146 | 82 | $25K |
| 88312 | 268 | 261 | $25K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 101 | 100 | $24K |
| 81003 | 13,423 | 8,372 | $24K | |
| 77066 | Tomosynthesis, mammo | 149 | 146 | $24K |
| 73030 | 1,644 | 1,555 | $24K | |
| 86706 | 2,909 | 2,854 | $23K | |
| 86765 | 2,425 | 2,347 | $23K | |
| 90846 | Family psychotherapy without the patient present, 50 minutes | 154 | 118 | $23K |
| 82948 | 17,397 | 13,315 | $23K | |
| 82951 | 2,099 | 1,870 | $22K | |
| 86787 | 2,455 | 2,370 | $22K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 764 | 763 | $22K |
| 88304 | 774 | 771 | $21K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 4,130 | 4,108 | $21K |
| 90847 | Family psychotherapy with the patient present, 50 minutes | 76 | 59 | $20K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 3,152 | 3,103 | $20K |
| 83550 | 3,089 | 3,015 | $19K | |
| 84153 | 1,367 | 1,343 | $19K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 96 | 54 | $19K |
| 86735 | 2,037 | 1,976 | $19K | |
| 87081 | 5,213 | 5,149 | $18K | |
| 81405 | 92 | 92 | $18K | |
| 93971 | 240 | 227 | $18K | |
| 73130 | 1,637 | 1,547 | $17K | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | 177 | 145 | $16K |
| 82105 | 1,375 | 1,335 | $16K | |
| 85730 | 10,286 | 9,846 | $16K | |
| 80356 | 3,309 | 2,541 | $16K | |
| 83540 | 3,402 | 3,320 | $16K | |
| 76870 | 232 | 228 | $15K | |
| 90633 | 1,260 | 1,259 | $15K | |
| 90707 | 691 | 689 | $15K | |
| 83020 | 1,343 | 1,292 | $15K | |
| 82274 | 1,187 | 1,181 | $14K | |
| D0220 | Intraoral - periapical first radiographic image | 1,809 | 1,778 | $14K |
| 90716 | 635 | 634 | $14K | |
| J2704 | Injection, propofol, 10 mg | 4,466 | 4,390 | $13K |
| 81361 | 109 | 109 | $12K | |
| 74018 | 1,041 | 1,034 | $12K | |
| 82043 | 2,676 | 2,644 | $12K | |
| 77062 | 77 | 76 | $11K | |
| 0124A | 260 | 260 | $11K | |
| 97165 | 97 | 96 | $11K | |
| 86141 | 3,248 | 3,167 | $11K | |
| 83735 | 12,291 | 11,671 | $11K | |
| 73502 | 531 | 495 | $11K | |
| J7030 | Infusion, normal saline solution , 1000 cc | 11,650 | 10,958 | $10K |
| 81025 | 2,249 | 2,151 | $10K | |
| 84146 | 600 | 571 | $10K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 16,279 | 15,208 | $10K |
| 45300 | 27 | 26 | $10K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 970 | 960 | $10K |
| 90698 | 813 | 813 | $10K | |
| 90723 | 958 | 956 | $10K | |
| 73090 | 1,068 | 926 | $10K | |
| 88141 | 355 | 348 | $10K | |
| 73140 | 738 | 727 | $10K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 13,740 | 12,650 | $10K |
| 82465 | 2,889 | 2,873 | $10K | |
| 84484 | 10,737 | 9,854 | $10K | |
| 81401 | 108 | 108 | $9K | |
| 99383 | 123 | 123 | $9K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 3,045 | 2,614 | $9K |
| D0120 | Periodic oral evaluation - established patient | 1,179 | 1,080 | $9K |
| 90647 | 875 | 873 | $9K | |
| 81257 | 134 | 134 | $9K | |
| H0038 | Self-help/peer services, per 15 minutes | 459 | 379 | $9K |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 7,515 | 6,662 | $9K |
| 90656 | 688 | 686 | $9K | |
| 87186 | 2,128 | 2,013 | $9K | |
| 97597 | 25 | 13 | $8K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 67 | 67 | $8K |
| 73590 | 846 | 762 | $8K | |
| 36430 | 28 | 24 | $8K | |
| 90732 | 83 | 83 | $7K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 3,921 | 3,735 | $7K |
| 82746 | 704 | 685 | $7K | |
| 92250 | 134 | 123 | $7K | |
| 82248 | 2,158 | 1,599 | $7K | |
| 83690 | 10,929 | 10,412 | $7K | |
| D1110 | Prophylaxis - adult | 530 | 509 | $7K |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 1,329 | 1,295 | $7K |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | 99 | 99 | $7K |
| 83001 | 403 | 382 | $7K | |
| 82677 | 336 | 324 | $6K | |
| 81243 | 187 | 187 | $6K | |
| 88300 | 730 | 696 | $6K | |
| 80354 | 1,264 | 1,001 | $6K | |
| 80047 | 401 | 395 | $6K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 9,579 | 8,877 | $6K |
| 74019 | 367 | 365 | $6K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 25 | 25 | $6K |
| 99051 | 672 | 662 | $6K | |
| D0140 | Limited oral evaluation - problem focused | 415 | 371 | $6K |
| 82803 | 2,557 | 2,377 | $6K | |
| 87535 | 160 | 158 | $5K | |
| 3074F | 27,058 | 20,444 | $5K | |
| 97035 | 344 | 123 | $5K | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 3,918 | 3,825 | $5K |
| D1120 | Prophylaxis - child | 69 | 69 | $5K |
| 73080 | 513 | 448 | $5K | |
| 73620 | 301 | 281 | $5K | |
| 76819 | Fetal biophysical profile; without non-stress testing | 61 | 50 | $5K |
| 90694 | 177 | 176 | $5K | |
| 82247 | 1,527 | 1,010 | $5K | |
| 90744 | 416 | 415 | $5K | |
| 51798 | 29 | 29 | $5K | |
| 90620 | 278 | 276 | $4K | |
| D0230 | Intraoral - periapical each additional radiographic image | 198 | 196 | $4K |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 1,268 | 1,149 | $4K |
| Q3014 | Telehealth originating site facility fee | 611 | 498 | $4K |
| 95117 | 304 | 221 | $4K | |
| 97026 | 533 | 173 | $4K | |
| 85045 | 1,477 | 1,411 | $4K | |
| 81400 | 96 | 96 | $4K | |
| 81255 | 108 | 108 | $4K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 4,193 | 3,936 | $4K |
| 84704 | 336 | 323 | $4K | |
| 90734 | 153 | 153 | $4K | |
| 86336 | 335 | 323 | $4K | |
| 83615 | 1,503 | 1,390 | $4K | |
| 73562 | 221 | 201 | $4K | |
| 83002 | 216 | 202 | $4K | |
| 85651 | 1,753 | 1,720 | $4K | |
| 81200 | 108 | 108 | $3K | |
| 81251 | 108 | 108 | $3K | |
| 82570 | 1,050 | 951 | $3K | |
| 97124 | 98 | 39 | $3K | |
| 90648 | 300 | 299 | $3K | |
| 84480 | 381 | 362 | $3K | |
| 86704 | 369 | 360 | $3K | |
| 94010 | 93 | 90 | $3K | |
| 82550 | 3,578 | 3,454 | $3K | |
| M0222 | Intravenous injection, bebtelovimab, includes injection and post administration monitoring | 42 | 42 | $3K |
| 84100 | 1,500 | 1,434 | $3K | |
| 73120 | 178 | 174 | $3K | |
| 83605 | 3,474 | 3,224 | $3K | |
| J7042 | 5% dextrose/normal saline (500 ml = 1 unit) | 1,943 | 1,886 | $3K |
| 90480 | 88 | 88 | $3K | |
| J1631 | Injection, haloperidol decanoate, per 50 mg | 138 | 128 | $3K |
| J0690 | Injection, cefazolin sodium, 500 mg | 686 | 663 | $3K |
| 73600 | 171 | 164 | $3K | |
| T2022 | Case management, per month | 63 | 37 | $3K |
| Q9963 | High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml | 1,294 | 1,281 | $3K |
| 81260 | 108 | 108 | $3K | |
| 84550 | 1,000 | 897 | $3K | |
| 92002 | 28 | 27 | $3K | |
| 96368 | 78 | 75 | $3K | |
| D1206 | Topical application of fluoride varnish | 656 | 656 | $3K |
| 0003A | 64 | 64 | $3K | |
| 72070 | 123 | 123 | $3K | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 64 | 64 | $3K |
| 86038 | 292 | 287 | $2K | |
| H2010 | Comprehensive medication services, per 15 minutes | 28 | 26 | $2K |
| 85379 | 1,841 | 1,800 | $2K | |
| J0290 | Injection, ampicillin sodium, 500 mg | 427 | 423 | $2K |
| 97161 | 25 | 25 | $2K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 2,593 | 2,338 | $2K |
| 0012A | 111 | 111 | $2K | |
| 99382 | 238 | 203 | $2K | |
| D2330 | 26 | 26 | $2K | |
| 86376 | 162 | 161 | $2K | |
| 82330 | 2,409 | 2,242 | $2K | |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | 80 | 43 | $2K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 68 | 68 | $2K |
| 96160 | 100 | 93 | $2K | |
| 97022 | 80 | 29 | $2K | |
| 85007 | 1,737 | 1,691 | $2K | |
| 80348 | 226 | 174 | $2K | |
| J7050 | Infusion, normal saline solution, 250 cc | 2,173 | 1,833 | $2K |
| 82952 | 278 | 271 | $2K | |
| 73070 | 213 | 190 | $2K | |
| 82397 | 1,690 | 1,653 | $2K | |
| 99404 | 14 | 14 | $2K | |
| 84156 | 808 | 732 | $2K | |
| 90710 | 97 | 97 | $2K | |
| D0145 | Oral evaluation for a patient under three years of age | 328 | 326 | $2K |
| J3475 | Injection, magnesium sulfate, per 500 mg | 1,278 | 1,210 | $2K |
| 84403 | 70 | 66 | $2K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 192 | 176 | $2K |
| 96376 | 1,638 | 1,591 | $2K | |
| 0011A | 113 | 105 | $2K | |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 1,979 | 1,771 | $1K |
| 77065 | Tomosynthesis, mammo | 12 | 12 | $1K |
| J2060 | Injection, lorazepam, 2 mg | 2,134 | 1,909 | $1K |
| 90700 | 119 | 119 | $1K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 708 | 676 | $1K |
| J2359 | Injection, olanzapine, 0.5 mg | 219 | 200 | $1K |
| J1741 | Injection, ibuprofen, 100 mg | 185 | 172 | $1K |
| 85384 | 493 | 434 | $1K | |
| 71250 | 13 | 13 | $1K | |
| 92550 | 29 | 29 | $1K | |
| 71101 | 171 | 163 | $1K | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 105 | 104 | $1K |
| 97116 | 38 | 13 | $1K | |
| D1208 | Topical application of fluoride, excluding varnish | 175 | 175 | $1K |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | 2,897 | 2,743 | $1K |
| 87338 | 118 | 118 | $1K | |
| 97168 | 13 | 12 | $1K | |
| 76830 | Ultrasound, transvaginal | 12 | 12 | $1K |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | 13 | 13 | $1K |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 3,911 | 3,759 | $1K |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 1,001 | 857 | $1K |
| J1630 | Injection, haloperidol, up to 5 mg | 1,511 | 1,402 | $1K |
| 92557 | 27 | 27 | $1K | |
| 73560 | 59 | 54 | $1K | |
| 87040 | 826 | 670 | $987.94 | |
| 80321 | 99 | 77 | $981.42 | |
| 86580 | 195 | 194 | $930.81 | |
| 96380 | 92 | 92 | $926.91 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 108 | 101 | $888.33 |
| 90696 | 72 | 72 | $868.25 | |
| D0274 | Bitewings - four radiographic images | 251 | 251 | $860.05 |
| 83516 | 60 | 57 | $841.87 | |
| 91320 | 56 | 55 | $806.01 | |
| 3077F | 4,103 | 3,481 | $795.00 | |
| 82962 | 115 | 99 | $776.86 | |
| 83527 | 82 | 82 | $767.19 | |
| 82010 | 852 | 794 | $765.10 | |
| 82977 | 154 | 152 | $755.07 | |
| 99401 | 14 | 14 | $751.39 | |
| 76857 | 16 | 14 | $740.50 | |
| J3360 | Injection, diazepam, up to 5 mg | 345 | 319 | $727.84 |
| 73060 | 103 | 100 | $725.16 | |
| 80051 | 58 | 55 | $687.79 | |
| 90662 | 31 | 31 | $613.80 | |
| 88112 | 13 | 13 | $604.42 | |
| 90381 | 42 | 42 | $603.06 | |
| J3411 | Injection, thiamine hcl, 100 mg | 712 | 643 | $562.42 |
| J1953 | Injection, levetiracetam, 10 mg | 158 | 153 | $559.21 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 1,716 | 1,435 | $535.96 |
| 3078F | 25,692 | 19,550 | $532.73 | |
| 3079F | 10,680 | 9,154 | $530.00 | |
| 99493 | 28 | 28 | $513.60 | |
| 90685 | 78 | 78 | $499.89 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 1,817 | 1,650 | $499.35 |
| 92134 | 12 | 12 | $481.05 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 23 | 23 | $478.88 |
| 87070 | 44 | 41 | $472.01 | |
| 86140 | 180 | 177 | $458.57 | |
| 0031A | 16 | 16 | $456.22 | |
| J8540 | Dexamethasone, oral, 0.25 mg | 219 | 180 | $432.18 |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 60 | 60 | $421.27 |
| 99232 | Subsequent hospital care, per day, moderate complexity | 14 | 14 | $373.70 |
| 83718 | 132 | 132 | $372.67 | |
| 87420 | 200 | 199 | $360.87 | |
| 90380 | 22 | 22 | $351.44 | |
| 73100 | 27 | 25 | $340.44 | |
| 90661 | 35 | 35 | $312.20 | |
| 92015 | Determination of refractive state | 14 | 14 | $310.70 |
| 80165 | 51 | 50 | $300.41 | |
| 84402 | 14 | 14 | $299.80 | |
| 90653 | 31 | 31 | $294.59 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 2,472 | 2,169 | $293.60 |
| 84478 | 131 | 131 | $291.98 | |
| 86705 | 55 | 51 | $282.68 | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 237 | 234 | $275.77 |
| 90674 | 17 | 17 | $265.86 | |
| 3075F | 6,990 | 6,186 | $265.00 | |
| 73552 | 40 | 38 | $256.45 | |
| 87177 | 26 | 24 | $220.72 | |
| 92587 | 12 | 12 | $204.21 | |
| J7510 | Prednisolone oral, per 5 mg | 71 | 69 | $180.00 |
| 82378 | 24 | 24 | $157.77 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 1,043 | 978 | $154.67 |
| J1790 | Injection, droperidol, up to 5 mg | 419 | 401 | $141.78 |
| 86593 | 30 | 30 | $130.75 | |
| 86255 | 15 | 14 | $127.34 | |
| 82947 | 68 | 61 | $122.14 | |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | 1,241 | 1,119 | $115.12 |
| 99494 | 13 | 13 | $110.34 | |
| 73660 | 25 | 24 | $94.55 | |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | 57 | 37 | $83.45 |
| G0008 | Administration of influenza virus vaccine | 170 | 170 | $63.56 |
| 93793 | 43 | 26 | $62.89 | |
| J0295 | Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm | 61 | 59 | $43.70 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 39 | 34 | $43.18 |
| 86430 | 14 | 14 | $41.27 | |
| 82150 | 50 | 50 | $41.21 | |
| J1815 | Injection, insulin, per 5 units | 67 | 54 | $40.13 |
| 85014 | 275 | 270 | $39.30 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 99 | 98 | $38.24 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 56 | 37 | $37.24 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 14 | 14 | $33.54 |
| 86708 | 12 | 12 | $27.78 | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 15 | 15 | $17.30 |
| 83930 | 15 | 14 | $16.19 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 31 | 30 | $16.05 |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | 12 | 12 | $14.57 |
| 87205 | 14 | 12 | $6.97 | |
| 99173 | 357 | 357 | $4.38 | |
| 82553 | 19 | 19 | $3.92 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 30 | 17 | $3.78 |
| J2004 | Injection, lidocaine hcl with epinephrine, 1 mg | 15 | 15 | $1.81 |
| J3490 | Unclassified drugs | 15 | 15 | $1.77 |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 17 | 12 | $0.35 |
| 99499 | 712 | 575 | $0.00 | |
| D0190 | 317 | 317 | $0.00 | |
| 1160F | 3,556 | 2,351 | $0.00 | |
| D0180 | 13 | 13 | $0.00 | |
| 1159F | 4,464 | 2,572 | $0.00 | |
| 99408 | 199 | 198 | $0.00 | |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 31 | 31 | $0.00 |
| 99080 | 639 | 322 | $0.00 | |
| D1330 | 1,154 | 1,154 | $0.00 | |
| 3080F | 1,729 | 1,493 | $0.00 | |
| 99406 | 197 | 197 | $0.00 | |
| 3044F | 180 | 175 | $0.00 | |
| 1220F | 990 | 990 | $0.00 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | 152 | 152 | $0.00 |
| 92551 | 369 | 369 | $0.00 | |
| 4293F | 67 | 67 | $0.00 |